Quarterly ResultMay 7, 2026, 04:21 PM
ICU Medical Q1 GAAP Revenue $530.2M; Non-GAAP Organic Revenue +1%
AI Summary
ICU Medical announced its first quarter 2026 financial results, reporting a GAAP revenue decline of 12% to $530.2 million, primarily due to the divestiture of its IV Solutions business. However, non-GAAP organic revenue, excluding the divestiture and foreign currency impacts, increased by 1%. The company achieved a GAAP net income of $30.1 million, a significant improvement from a net loss in the prior year, and adjusted diluted EPS grew to $1.97.
Key Highlights
- GAAP revenue declined 12% year-over-year to $530.2 million.
- Non-GAAP organic revenue increased 1% year-over-year, excluding divestiture and currency impacts.
- GAAP net income was $30.1 million, or $1.20 per diluted share, compared to a loss of $(15.5) million.
- Adjusted diluted EPS rose to $1.97 from $1.72 in Q1 2025.
- GAAP gross margin improved to 39% from 35% in the prior year.
- Consumables GAAP revenue increased by $12.1 million to $278.3 million.
- Infusion Systems GAAP revenue increased by $13.3 million to $179.6 million.
- Free cash flow was $27.6 million, down from $36.7 million in Q1 2025.